Oarsman Capital Inc. trimmed its holdings in UnitedHealth Group Inc (NYSE:UNH) by 16.5% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 2,805 shares of the healthcare conglomerate’s stock after selling 555 shares during the quarter. Oarsman Capital Inc.’s holdings in UnitedHealth Group were worth $746,000 at the end of the most recent reporting period.
Other large investors have also bought and sold shares of the company. Welch Group LLC purchased a new stake in UnitedHealth Group in the second quarter valued at $106,000. FNY Investment Advisers LLC purchased a new stake in UnitedHealth Group in the third quarter valued at $106,000. Blue Chip Partners Inc. purchased a new stake in UnitedHealth Group in the second quarter valued at $107,000. Fort L.P. purchased a new stake in UnitedHealth Group in the second quarter valued at $119,000. Finally, Polaris Greystone Financial Group LLC purchased a new stake in UnitedHealth Group in the third quarter valued at $120,000. 85.45% of the stock is currently owned by institutional investors.
Several equities research analysts have recently issued reports on the stock. Bank of America increased their target price on shares of UnitedHealth Group from $315.00 to $320.00 and gave the stock a “buy” rating in a research note on Wednesday, October 17th. Cantor Fitzgerald reissued a “buy” rating and set a $300.00 target price on shares of UnitedHealth Group in a research note on Thursday, August 9th. Jefferies Financial Group increased their target price on shares of UnitedHealth Group from $270.00 to $311.00 and gave the stock a “buy” rating in a research note on Wednesday, October 3rd. ValuEngine raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Tuesday, October 2nd. Finally, Zacks Investment Research raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $299.00 target price on the stock in a research note on Tuesday, September 25th. Two research analysts have rated the stock with a hold rating, twenty-one have assigned a buy rating and one has assigned a strong buy rating to the stock. UnitedHealth Group currently has a consensus rating of “Buy” and a consensus price target of $289.86.
UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, October 16th. The healthcare conglomerate reported $3.41 earnings per share for the quarter, topping the consensus estimate of $3.30 by $0.11. UnitedHealth Group had a net margin of 5.71% and a return on equity of 23.62%. The firm had revenue of $56.56 billion during the quarter, compared to the consensus estimate of $56.34 billion. During the same quarter in the prior year, the firm earned $2.66 EPS. The company’s revenue for the quarter was up 12.4% on a year-over-year basis. On average, sell-side analysts expect that UnitedHealth Group Inc will post 12.81 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Thursday, December 13th. Investors of record on Monday, December 3rd will be given a dividend of $0.90 per share. The ex-dividend date is Friday, November 30th. This represents a $3.60 annualized dividend and a dividend yield of 1.38%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 35.75%.
In other UnitedHealth Group news, CEO Steven H. Nelson sold 8,142 shares of the stock in a transaction dated Thursday, September 13th. The shares were sold at an average price of $265.00, for a total value of $2,157,630.00. Following the completion of the sale, the chief executive officer now owns 22,496 shares in the company, valued at approximately $5,961,440. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Kenneth Irwin Shine sold 163 shares of the stock in a transaction dated Friday, November 9th. The shares were sold at an average price of $274.83, for a total transaction of $44,797.29. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 54,338 shares of company stock valued at $14,516,459. Insiders own 0.87% of the company’s stock.
TRADEMARK VIOLATION WARNING: This news story was reported by WKRB News and is the sole property of of WKRB News. If you are accessing this news story on another website, it was illegally copied and reposted in violation of US and international trademark & copyright laws. The original version of this news story can be viewed at https://www.wkrb13.com/2018/11/25/oarsman-capital-inc-sells-555-shares-of-unitedhealth-group-inc-unh.html.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
See Also: How to calculate compound interest
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.